Organization
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
2 abstracts
Abstract
Phase 3 trial evaluating efficacy and safety of odronextamab plus CHOP vs rituximab plus CHOP in previously untreated diffuse large B-cell lymphoma (DLBCL; OLYMPIA-3).Org: Division of Blood Disorders, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, Namık Kemal Üniversitesi, Nantes University Hospital, Centre Hospitalier Universitaire (CHU) de Poitiers,
Abstract
Patient preferences for use of archived biospecimens in Turkey.Org: Ankara University Faculty of Medicine, Ankara Yıldırım Beyazıt University Faculty of Medicine Department of Medical Oncology, Bakirköy Dr. Sadi Konuk Training and Research Hospital, Trakya University School of Medicine, University of Health Sciences and Pharmacy,